Search research articles
Contact Us
Filters
Showing results (101-110 of 376) with videos related to
Page
of 38
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy
|
July 12, 2020
2019 ESC/EAS Guidelines for management of dyslipidaemia: strengths and limitations
Michel Zeitouni, Pierre Sabouret, Mathieu Kerneis, et al.
Circulation
|
November 23, 2006
High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction
Farzin Beygui, Jean-Philippe Collet, Jean-Jacques Benoliel, et al.
Circulation. Cardiovascular Interventions
|
January 12, 2019
Antithrombotic Therapy After Transcatheter Aortic Valve Replacement
Paul Guedeney, Roxana Mehran, Jean-Philippe Collet, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
March 5, 2019
Do Patients need Lifelong β-Blockers after an Uncomplicated Myocardial Infarction?
Michel Zeitouni, Mathieu Kerneis, Benoit Lattuca, et al.
Drugs & Aging
|
April 7, 2019
Elderly Patients with ST-Segment Elevation Myocardial Infarction: A Patient-Centered Approach
Benoit Lattuca, Mathieu Kerneis, Michel Zeitouni, et al.
Journal of Clinical Medicine
|
November 14, 2023
Transcatheter Mitral Valve Replacement Using Transcatheter Aortic Valve or Dedicated Devices: Current Evidence and Future Prospects
Victor Quentin, Jules Mesnier, Clémence Delhomme, et al.
Heart (British Cardiac Society)
|
March 15, 2019
Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation
Vincent Johan Nijenhuis, Jorn Brouwer, Lars Søndergaard, et al.
Angiology
|
June 13, 2015
Optimal Duration of Dual Antiplatelet Therapy After DES Implantation: A Meta-Analysis of 11 Randomized Trials
Monica Verdoia, Alon Schaffer, Lucia Barbieri, et al.
European Heart Journal. Acute Cardiovascular Care
|
April 30, 2015
Optimal timing of initiation of oral P2Y12-receptor antagonist therapy in patients with non-ST elevation acute coronary syndromes. Lessons learnt from the ACCOAST-trial
Uwe Zeymer, Gilles Montalescot, Diego Ardissino, et al.
JACC. Cardiovascular Interventions
|
August 6, 2021
Antithrombotic Therapy After Transcatheter Aortic Valve Replacement
Davide Capodanno, Jean-Philippe Collet, George Dangas, et al.
Page
of 38
Search research articles
Search
Showing results (101-110 of 376) with videos related to
Sort By:
Page
of 38
European Heart Journal. Cardiovascular Pharmacotherapy
|
July 12, 2020
2019 ESC/EAS Guidelines for management of dyslipidaemia: strengths and limitations
Michel Zeitouni, Pierre Sabouret, Mathieu Kerneis, et al.
Circulation
|
November 23, 2006
High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction
Farzin Beygui, Jean-Philippe Collet, Jean-Jacques Benoliel, et al.
Circulation. Cardiovascular Interventions
|
January 12, 2019
Antithrombotic Therapy After Transcatheter Aortic Valve Replacement
Paul Guedeney, Roxana Mehran, Jean-Philippe Collet, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
March 5, 2019
Do Patients need Lifelong β-Blockers after an Uncomplicated Myocardial Infarction?
Michel Zeitouni, Mathieu Kerneis, Benoit Lattuca, et al.
Drugs & Aging
|
April 7, 2019
Elderly Patients with ST-Segment Elevation Myocardial Infarction: A Patient-Centered Approach
Benoit Lattuca, Mathieu Kerneis, Michel Zeitouni, et al.
Journal of Clinical Medicine
|
November 14, 2023
Transcatheter Mitral Valve Replacement Using Transcatheter Aortic Valve or Dedicated Devices: Current Evidence and Future Prospects
Victor Quentin, Jules Mesnier, Clémence Delhomme, et al.
Heart (British Cardiac Society)
|
March 15, 2019
Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation
Vincent Johan Nijenhuis, Jorn Brouwer, Lars Søndergaard, et al.
Angiology
|
June 13, 2015
Optimal Duration of Dual Antiplatelet Therapy After DES Implantation: A Meta-Analysis of 11 Randomized Trials
Monica Verdoia, Alon Schaffer, Lucia Barbieri, et al.
European Heart Journal. Acute Cardiovascular Care
|
April 30, 2015
Optimal timing of initiation of oral P2Y12-receptor antagonist therapy in patients with non-ST elevation acute coronary syndromes. Lessons learnt from the ACCOAST-trial
Uwe Zeymer, Gilles Montalescot, Diego Ardissino, et al.
JACC. Cardiovascular Interventions
|
August 6, 2021
Antithrombotic Therapy After Transcatheter Aortic Valve Replacement
Davide Capodanno, Jean-Philippe Collet, George Dangas, et al.
Page
of 38